Biblio
Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility. Kidney Res Clin Pract. 2019;38(2):176-185.
BASIC FIBROBLAST GROWTH FACTOR REDUCES THE FUNCTIONAL AND STRUCTURAL DAMAGE IN CHRONIC KIDNEY DISEASE. Am J Physiol Renal Physiol. 2013.